Home › Pulmonary Fibrosis
Pulmonary Fibrosis clinical trials recruiting in the U.S.
21 studies for Pulmonary Fibrosis are recruiting participants at sites across the United States.
Pulmonary fibrosis (Idiopathic pulmonary fibrosis or IPF) is a condition where the tissue deep in the lungs becomes scarred over time. Find symptoms.
Cities with the most studies
By state
- Arizona3 studies
- California5 studies
- Florida3 studies
- Illinois4 studies
- Massachusetts5 studies
- Minnesota3 studies
- North Carolina3 studies
- Pennsylvania5 studies
- South Carolina3 studies
- Texas3 studies
Recently updated studies
Pulmonary Fibrosis Foundation Community Registry
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05382572Role of Genetic Factors in the Development of Lung Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 90 · All sexes · Updated Sep 10, 2026 · NCT00001532Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
RecruitingObservational study
1 Month – 115 Years · All sexes · Updated Sep 9, 2026 · NCT00001456Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 3, 2026 · NCT07284602Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT00258570Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511Nucleoside Therapy in Patients With Telomere Biology Disorders
RecruitingPhase 1
Ages 1 to 70 · All sexes · Updated Aug 4, 2026 · NCT06817590H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 28, 2026 · NCT06325696Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 14, 2026 · NCT07572383Interstitial Lung Disease Research Unit Biobank
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05392881Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT06162884Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT01531257Advanced Imaging for Pulmonary Fibrosis
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Apr 22, 2026 · NCT06532071Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
Recruiting
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT06751069Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06940427Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Feb 27, 2026 · NCT03535545Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jan 21, 2026 · NCT05120934Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
RecruitingPhase 1/2
Ages 18 to 60 · All sexes · Updated Jan 13, 2026 · NCT03500731Explanted Lung Tissues With Pulmonary Fibrosis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 13, 2026 · NCT00515567Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Nov 10, 2025 · NCT06567717From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.